Serum S100A12 (EN-RAGE) Levels in Patients with Decreased Renal Function and Subclinical Chronic Inflammatory Disease | Zendy

Oskar Zakiyanov | Zendy; Marta Kalousová | Zendy; Vítězslav Kříha | Zendy; Tomáš Zima | Zendy; Vladimı́r Tesař | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serum S100A12 (EN-RAGE) Levels in Patients with Decreased Renal Function and Subclinical Chronic Inflammatory Disease

Author(s) -

Oskar Zakiyanov,

Marta Kalousová,

Vítězslav Kříha,

Tomáš Zima,

Vladimı́r Tesař

Publication year - 2011

Publication title -

kidney and blood pressure research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.806

H-Index - 51

eISSN - 1423-0143

pISSN - 1420-4096

DOI - 10.1159/000329291

Subject(s) - orosomucoid , medicine , fibrinogen , renal function , inflammation , endocrinology , glycation , c reactive protein , kidney disease , rage (emotion) , calprotectin , immunology , disease , receptor , biology , glycoprotein , biochemistry , inflammatory bowel disease , neuroscience

The calcium-binding protein S100A12 (EN-RAGE) causes inflammation through interaction with the multiligand receptor for advanced glycation end products (RAGE). The aim of the study was to determine S100A12 levels and describe their relationship to inflammatory markers in patients with decreased renal function.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research